Symptoms compatible with functional bowel disorders are common in patients with quiescent ulcerative colitis and influence the quality of life but not the course of the disease

by Georgios Mavroudis, Magnus Simren, Börje Jonefjäll, Lena Öhman, Hans Strid
Published 2019-02-01

Faecal secretogranin and chromogranin levels persist over time and are unrelated to disease history and outcome in patients with ulcerative colitis

by Maria K. Magnusson, Anders Lasson, Mats Stridsberg, Stefan Isaksson, Hans Strid, Lena Öhman
Published 2018-01-01

Fecal microbiota dynamics during disease activity and remission in newly diagnosed and established ulcerative colitis

by Lena Öhman, Anders Lasson, Anna Strömbeck, Stefan Isaksson, Marcus Hesselmar, Magnus Simrén, Hans Strid, Maria K. Magnusson
Published 2021-04-01

Fecal microbiota composition is linked to the postoperative disease course in patients with Crohn’s disease

by Anna Strömbeck, Anders Lasson, Hans Strid, Johanna Sundin, Per-Ove Stotzer, Magnus Simrén, Maria K. Magnusson, Lena Öhman
Published 2020-05-01

Impaired Luminal Control of Intestinal Macrophage Maturation in Patients With Ulcerative Colitis During RemissionSummary

by Lujain Maasfeh, Anetta Härtlova, Stefan Isaksson, Johanna Sundin, Georgios Mavroudis, Otto Savolainen, Hans Strid, Lena Öhman, Maria K. Magnusson
Published 2021-01-01

A distinct gut microbiota composition in patients with ankylosing spondylitis is associated with increased levels of fecal calprotectin

by Eva Klingberg, Maria K. Magnusson, Hans Strid, Anna Deminger, Arne Ståhl, Johanna Sundin, Magnus Simrén, Hans Carlsten, Lena Öhman, Helena Forsblad-d’Elia
Published 2019-11-01

Spontaneous colitis in Muc2-deficient mice reflects clinical and cellular features of active ulcerative colitis.

by Ulf A Wenzel, Maria K Magnusson, Anna Rydström, Caroline Jonstrand, Julia Hengst, Malin E V Johansson, Anna Velcich, Lena Öhman, Hans Strid, Henrik Sjövall, Gunnar C Hansson, Mary Jo Wick
Published 2014-01-01

Real-world effectiveness of vedolizumab in inflammatory bowel disease: week 52 results from the Swedish prospective multicentre SVEAH study

by Carl Eriksson, Sara Rundquist, Vyron Lykiardopoulos, Ruzan Udumyan, Per Karlén, Olof Grip, Charlotte Söderman, Sven Almer, Erik Hertervig, Jan Marsal, Jenny Gunnarsson, Carolina Malmgren, Jenny Delin, Hans Strid, Mats Sjöberg, David Öberg, Daniel Bergemalm, Henrik Hjortswang, Jonas Halfvarson
Published 2021-07-01